No Data
No Data
Zhuhai Rundu Pharmaceutical (002923.SZ): CEP certificate obtained for the active pharmaceutical ingredient of voriconazole.
On July 8th, Gelunhui reported that Zhuhai Rundu Pharmaceutical (002923.SZ) recently received the Certificate of Suitability to Monograph of European Pharmacopoeia (CEP certificate) issued by the European Directorate for the Quality of Medicines & HealthCare (EDQM) for voriconazole active pharmaceutical ingredient. This drug is a broad-spectrum triazole antifungal drug developed by Pfizer in the United States, and its mechanism of action is to inhibit the cytochrome P450-mediated pathway in fungi.
Zhuhai Rundu Pharmaceutical Gets Nod for Valsartan Hydrochlorothiazide Tablets
Zhuhai Rundu Pharmaceutical's (SHE:002923) valsartan hydrochlorothiazide tablets received a drug registration certificate from Chinese drug regulator National Medical Products Administration, accordin
Zhuhai Rundu Pharmaceutical (002923.SZ): The registration certificate for Valsartan Hydrochlorothiazide tablets has been obtained.
Zhuhai Rundu Pharmaceutical (002923.SZ) announced that the company has recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for the drug "Valsartan Hydrochlorothiazide Tablets". It is reported that Valsartan Hydrochlorothiazide Tablets are a compound solid preparation of valsartan and hydrochlorothiazide developed by Novartis, which was launched in the United States in March 1998. This product is used to treat mild to moderate primary hypertension in patients whose blood pressure cannot be effectively controlled by a single medication, and is not suitable for initial treatment of hypertension. The receipt of the "Drug Registration Certificate" by this product marks that the company has obtained the approval to produce and market this pharmaceutical.
Rundu Pharmaceutical Probes Allegations of Toxic Food Production
Zhuhai Rundu Pharmaceutical (SHE:002923) is investigating after a Chinese procuratorate accused the company of allegedly producing and selling toxic and harmful food, the company said in its filing on
Rundu Co., Ltd. (002923.SZ) plans to pay 2 yuan for 10 shares to be deducted from interest on May 31
Rundu Co., Ltd. (002923.SZ) announced that the company's 2023 equity distribution plan: to all shareholders every 10...
There May Be Reason For Hope In Zhuhai Rundu Pharmaceutical's (SZSE:002923) Disappointing Earnings
The market was pleased with the recent earnings report from Zhuhai Rundu Pharmaceutical Co., Ltd. (SZSE:002923), despite the profit numbers being soft. We think that investors might be looking at som
No Data